Close
Show
Home Clinical Trials

Clinical Trials

World Pharma Today clinical Trials covers all updates & latest in clinical trials news, Pharma clinical trial company news, clinical trials technology…

Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy  from Bristol Myers Squibb

Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA),...


Biohaven Pharmaceutical Holding Company Ltd. announced that it entered into a worldwide license agreement with...
Thermo Fisher Expands Clinical and Commercial Capabilities for Plasmid DNA Manufacturing

Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic...


Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research...
Velocity Clinical Research makes tech investments to strengthen patient and client engagement in clinical trials

Velocity Clinical Research makes tech investments to strengthen patient and client engagement in clinical...


Velocity Clinical Research, the largest fully integrated clinical site organization, announces three key tech investments...
New COVID-19 Clinical Trial Supported by Octapharma USA

Thermo Fisher Scientific Partners with Medidata Acorn AI to Optimize Clinical Research Site Selection...


Thermo Fisher Scientific Inc., the world leader in serving science, announced a multiyear partnership with...
Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate


Valneva SE, a specialty vaccine company, announced the initiation of a Phase 3 trial in...
Mayo Clinic Collaborates with Vocalis Health for Clinical Development of Vocal Biomarkers

ZS and IgniteData partner to transform patient data automation for clinical trials


The global professional services firm ZS announced today that it has entered into a strategic...
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age

Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to...


Pfizer Inc. and BioNTech SE announced the initiation of a clinical study to evaluate the...

Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant


Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir,...
Catalent Launches New Xpress Pharmaceutics Service to Expedite Development of Oral Drugs for Adaptive Phase 1 Clinical Trials

Catalent Launches New Xpress Pharmaceutics Service to Expedite Development of Oral Drugs for Adaptive...


Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize...
Immune Biosolutions reports that its lead immunotherapy product IBIO123 neutralizes 100% of the SARS-CoV-2, including Omicron

Immune Biosolutions reports that its lead immunotherapy product IBIO123 neutralizes 100% of the SARS-CoV-2,...


Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug...